Sonnet BioTherapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity - Schedule of Warrants Outstanding (Details)

Stockholders' Equity - Schedule of Warrants Outstanding (Details)	12 Months Ended
	Dec. 31, 2016 $ / shares shares
Warrants outstanding, Weighted-average remaining contractual life ( in years)	1 year 6 months
Warrant [Member]
Number of warrants, outstanding	9,222,032
Number of warrants exercisable	9,222,032
Range 1 [Member] \| Warrant [Member]
Range of exercise prices, upper limit \| $ / shares	$ 4.00
Number of warrants, outstanding	7,439,631
Warrants outstanding, Weighted-average remaining contractual life ( in years)	1 year 6 months
Number of warrants exercisable	7,439,631
Range 2 [Member] \| Warrant [Member]
Range of exercise prices, lower limit \| $ / shares	$ 3.00
Range of exercise prices, upper limit \| $ / shares	$ 3.99
Number of warrants, outstanding	499,901
Warrants outstanding, Weighted-average remaining contractual life ( in years)	2 years 7 months 6 days
Number of warrants exercisable	499,901
Range 3 [Member] \| Warrant [Member]
Range of exercise prices, lower limit \| $ / shares	$ 2.00
Range of exercise prices, upper limit \| $ / shares	$ 2.99
Number of warrants, outstanding	779,500
Warrants outstanding, Weighted-average remaining contractual life ( in years)	3 years 1 month 6 days
Number of warrants exercisable	779,500
Range 4 [Member] \| Warrant [Member]
Range of exercise prices, lower limit \| $ / shares	$ 1.00
Range of exercise prices, upper limit \| $ / shares	$ 1.99
Number of warrants, outstanding	503,000
Warrants outstanding, Weighted-average remaining contractual life ( in years)	4 years 3 months 18 days
Number of warrants exercisable	503,000